InvestorsHub Logo
Followers 1055
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: None

Wednesday, 05/24/2017 1:38:45 PM

Wednesday, May 24, 2017 1:38:45 PM

Post# of 3504
Entolimod (CBLB502)-"Our clinical studies of entolimod in 150 healthy human subjects have demonstrated the safety profile of entolimod and established the dose-dependent effect of entolimod on efficacy biomarkers in humans".

"The FDA granted entolimod both Fast Track and Orphan Drug status for reducing the risk of death following a potentially lethal dose of total body irradiation during or after a radiation disaster".

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.